Drug and alcohol review · 2026
Quitline Counsellors' Experiences With Vaping and Nicotine Replacement Therapy for Smoking Cessation in Australian Drug and Alcohol Services.
СтатьяНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Rich Jane L, Segan Catherine J, Trigg Joshua, Guillaumier Ashleigh, Moore Lyndell, Manning Victoria, Dunlop Adrian, Garfield Joshua B B, Daglish Mark, Walker Natalie, Bullen Chris, Baird Donita, Lubman Dan, Gartner Coral, Baker Amanda, Bonevski Billie
Аннотация
INTRODUCTION: In Australia, people undergoing inpatient treatment for alcohol and other drug (AOD) use disorders have a high prevalence of tobacco smoking. Smoking cessation support is routinely offered to clients within inpatient withdrawal settings, but continued support post-discharge typically is not. The current study qualitatively explores attitudes and experiences of Quitline counsellors involved in a two-armed trial for clients with provision of 12 weeks of nicotine vaping products (NVPs) or combination nicotine replacement therapy (cNRT).
METHODS: Two focus groups of Quitline counsellors (six per group) explored how they felt about training received, their beliefs and attitudes about NVPs and cNRT for smoking cessation for AOD-use population and their wider experience supporting AOD clients. Data were inductively coded.
RESULTS: Six themes were identified: (i) Counsellor Readiness and Professional Adaptation to Emerging Cessation Tools; (ii) Addressing Complexity: Behavioural Support in Multi-Substance Recovery Contexts; (iii) Client Preferences and Product Engagement in Cessation Support; (iv) Continuity of Care: Bridging Residential Treatment and Community Support; (v) Enablers of Quality Practice: Training, Resources and Organisational Support; and (vi) Service Integration and Boundary Management in Specialised Populations.
DISCUSSION AND CONCLUSIONS: The agility of Quitline services models their potential to partner with clinical research teams and AOD services to build the evidence-base around the effectiveness of reduced-harm nicotine products for people with complex needs. The Victorian Quitline partnership with the NEAT trial produced a comprehensive service model assisting people seeking AOD treatment to quit smoking that highlights the workforce as a modifiable factor by involving staff in evidence-building adaptability.
METHODS: Two focus groups of Quitline counsellors (six per group) explored how they felt about training received, their beliefs and attitudes about NVPs and cNRT for smoking cessation for AOD-use population and their wider experience supporting AOD clients. Data were inductively coded.
RESULTS: Six themes were identified: (i) Counsellor Readiness and Professional Adaptation to Emerging Cessation Tools; (ii) Addressing Complexity: Behavioural Support in Multi-Substance Recovery Contexts; (iii) Client Preferences and Product Engagement in Cessation Support; (iv) Continuity of Care: Bridging Residential Treatment and Community Support; (v) Enablers of Quality Practice: Training, Resources and Organisational Support; and (vi) Service Integration and Boundary Management in Specialised Populations.
DISCUSSION AND CONCLUSIONS: The agility of Quitline services models their potential to partner with clinical research teams and AOD services to build the evidence-base around the effectiveness of reduced-harm nicotine products for people with complex needs. The Victorian Quitline partnership with the NEAT trial produced a comprehensive service model assisting people seeking AOD treatment to quit smoking that highlights the workforce as a modifiable factor by involving staff in evidence-building adaptability.